These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 1348655

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Flupenthixol versus haloperidol in acute psychosis.
    Parent M, Toussaint C.
    Pharmatherapeutica; 1983; 3(5):354-64. PubMed ID: 6844372
    [Abstract] [Full Text] [Related]

  • 43. Effects of neuroleptic reduction in schizophrenic outpatients receiving high doses.
    Leblanc G, Cormier H, Gagné MA, Vaillancourt S.
    Can J Psychiatry; 1994 May; 39(4):223-9. PubMed ID: 7913872
    [Abstract] [Full Text] [Related]

  • 44. Selection of neuroleptic dosage.
    Teicher MH, Baldessarini RJ.
    Arch Gen Psychiatry; 1985 Jun; 42(6):636-7. PubMed ID: 2860885
    [No Abstract] [Full Text] [Related]

  • 45. Optimizing outcomes in schizophrenia: long-acting depots and long-term treatment.
    Morrissette DA, Stahl SM.
    CNS Spectr; 2012 Nov; 17 Suppl 1():10-21. PubMed ID: 23462201
    [Abstract] [Full Text] [Related]

  • 46. Effective clinical response at low plasma levels of haloperidol in Japanese schizophrenics with acute psychotic state.
    Jibiki I, Kubota T, Fujimoto K, Sakamoto H, Hasegawa M, Furuta H, Yamaguchi N.
    Jpn J Psychiatry Neurol; 1993 Sep; 47(3):627-9. PubMed ID: 8301878
    [No Abstract] [Full Text] [Related]

  • 47. The Dose Reduction in Schizophrenia (DORIS) Study: a final report.
    Hirschowitz J, Hitzemann R, Piscani K, Burr G, Frecska E, Culliton D, Mann M, Curtis C.
    Schizophr Res; 1997 Jan 17; 23(1):31-43. PubMed ID: 9050126
    [Abstract] [Full Text] [Related]

  • 48. Depot neuroleptic medication and serum levels by radioreceptor assay: prolactin concentration, electrocardiogram abnormalities and six-month outcome.
    Turbott J, Villiger J, Hunter L.
    Aust N Z J Psychiatry; 1987 Sep 17; 21(3):327-38. PubMed ID: 3435373
    [Abstract] [Full Text] [Related]

  • 49. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D, Delgado A, Bouju S, Comet D, Chiariny JF.
    Encephale; 2013 May 17; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Treatment response to olanzapine and haloperidol and its association with dopamine D receptor occupancy in first-episode psychosis.
    Zipursky RB, Christensen BK, Daskalakis Z, Epstein I, Roy P, Furimsky I, Sanger T, Kapur S.
    Can J Psychiatry; 2005 Jul 17; 50(8):462-9. PubMed ID: 16127964
    [Abstract] [Full Text] [Related]

  • 52. Determining the optimal dose of haloperidol in first-episode psychosis.
    Oosthuizen P, Emsley RA, Turner J, Keyter N.
    J Psychopharmacol; 2001 Dec 17; 15(4):251-5. PubMed ID: 11769818
    [Abstract] [Full Text] [Related]

  • 53. Antipsychotic drug side effects: their relationship to dose.
    Kane JM.
    J Clin Psychiatry; 1985 May 17; 46(5 Pt 2):16-21. PubMed ID: 2859276
    [Abstract] [Full Text] [Related]

  • 54. Depot fluphenazine: risk/benefit ratio.
    Glazer WM.
    J Clin Psychiatry; 1984 May 17; 45(5 Pt 2):28-35. PubMed ID: 6370986
    [Abstract] [Full Text] [Related]

  • 55. Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables.
    Stanković Z, Britvić D, Vuković O, Ille T.
    Psychiatr Danub; 2008 Mar 17; 20(1):42-52. PubMed ID: 18376330
    [Abstract] [Full Text] [Related]

  • 56. [The position of the depot-neuroleptics in the therapy of chronic psychoses. Experience with fluphenazine-decanoate].
    Auch W.
    Med Welt; 1970 Oct 10; 21(41):1785-8. PubMed ID: 5471981
    [No Abstract] [Full Text] [Related]

  • 57. [Depot antipsychotics in the year 2011].
    Knegtering H, Oolders H, Ruijsink MA, van der Moolen AE.
    Tijdschr Psychiatr; 2011 Oct 10; 53(2):95-105. PubMed ID: 21319066
    [Abstract] [Full Text] [Related]

  • 58. Managing psychotic symptoms when the diagnosis is unclear.
    Ninan PT, Shelton S.
    Hosp Community Psychiatry; 1993 Feb 10; 44(2):107-8. PubMed ID: 8432491
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.